Navigation Links
Final agenda available for CRF Conference on Stem Cell Therapy for Heart Disease
Date:1/8/2014

WHAT:

The final agenda for the Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://www.crf.org/celltherapy/the-conference/agenda. The conference, which will be held January 22-24, 2014, is the premier meeting dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

This year's conference will focus on preclinical and clinical studies and their paths toward optimizing outcomes. The most promising molecular, cellular, and tissue products will be presented. Presentations of key activities at state, federal, and international levels will also be highlighted as measures of the progress ahead.

WHY:

Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 13th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has provided both a strong foundation for the conduct of large scale, pivotal studies, as well as insights into mechanisms of cardiovascular repair that will enhance the design of further investigation.

Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies. Sessions will focus on:

  • Molecular and Cellular Pathways: Regulating Biologic Function
  • Mechanistic Insights and Hypothesis
  • Moving Toward Tissue as Therapy: Micro- and Macro-Structure Strategies
  • STEMI and Acute Injury Studies
  • Chronic Injury and Vascular Insufficiency
  • Chronic Left Ventricular Dysfunction and Heart Failure
  • Patients-In-Need: Defining and Refining our Approach to Target Populations
  • Data in Hand: Looking for Answers in Meta-Analytic Studies
  • Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine

WHO:

Course Director

Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Course Co-Directors

Jozef Bartunek, MD, PhD

Henricus J. Duckers, MD, PhD

Amit Patel, MD, MS

Marc S. Penn, MD, PhD

Thomas Povsic, MD

Gordana Vunjak-Novakovic, PhD

Joseph Wu, MD, PhD

Wojtek Wojakowski, MD, PhD

WHEN:

January 22-24, 2014

WHERE:

Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

For more information visit: http://www.crf.org/celltherapy.

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related biology news :

1. Planet under Pressure conference, London: Final statement
2. Sequencing works in clinical setting to help -- finally -- get a diagnosis
3. NYBG press publishes final volume of landmark Intermountain Flora series
4. Finalists of air pollution sensor challenge announced
5. Dark matter made visible before the final cut
6. Researchers attack HIVs final defenses before drug-resistant mutations emerge
7. WPI Biomedical Technology in final 4 of international business plan contest
8. Final chapter to 60-year-old blood group mystery
9. Fueling fitness on the final frontier
10. Finally mapped: The brain region that distinguishes bits from bounty
11. The Sackler Institute unveils a global research agenda for nutrition science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... Poway, California (PRWEB) , ... October 10, 2017 , ... ... afternoon speaking at his local San Diego Rotary Club. The event ... San Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving ... marijuana products targeting the needs of consumers who are incorporating medical marijuana into ... in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving ...
Breaking Biology Technology: